Evidence map›Paper›PMID 24233004›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2014

Imaging of amyloid deposition in human brain using positron emission tomography and [18F]FACT: comparison with [11C]PIB.

Hiroshi Ito, Hitoshi Shinotoh, Hitoshi Shimada, Michie Miyoshi, Kazuhiko Yanai, Nobuyuki Okamura, Harumasa Takano, Hidehiko Takahashi, Ryosuke Arakawa, Fumitoshi Kodaka and 5 more

Registry-linked trialAbstract readComparative StudyEvaluation Study
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04250376 (The Use of Transcranial Focused Ultrasound for the Treatment of Neurodegenerative Dementias), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04250376 naunknown statusnot on this mapstarted 2017, after this paper: background citation

The Use of Transcranial Focused Ultrasound for the Treatment of Neurodegenerative Dementias

TypeinterventionalSponsorNeurological Associates of West Los AngelesRan2017 to 2025Enrolled100ConditionsMild Cognitive Impairment, Mild Dementia, Parkinson Disease, Alzheimer DiseaseArmsFocused Transcranial Ultrasound
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. [European journal of nuclear medicine and molecular imaging · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Annals of nuclear medicine · 2018
    Article
  8. Article
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Hiroshi Ito
Hitoshi Shinotoh
Hitoshi Shimada
Michie Miyoshi
Kazuhiko Yanai
Nobuyuki Okamura
Harumasa Takano
Hidehiko Takahashi
Ryosuke Arakawa
Fumitoshi Kodaka
Maiko Ono
Yoko Eguchi
Makoto Higuchi
Toshimitsu Fukumura
Tetsuya Suhara
Tohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe characteristic neuropathological changes in Alzheimer's disease (AD) are deposition of amyloid senile plaques and neurofibrillary tangles. The (18)F-labeled amyloid tracer, [(18)F]2-[(2-{(E)-2-[2-(dimethylamino)-1,3-thiazol-5-yl]vinyl}-1,3-benzoxazol-6-yl)oxy]-3-fluoropropan-1-ol (FACT), one of the benzoxazole derivatives, was recently developed. In the present study, deposition of amyloid senile plaques was measured by positron emission tomography (PET) with both [(11)C]Pittsburgh compound B (PIB) and [(18)F]FACT in the same subjects, and the regional uptakes of both radiotracers were directly compared.

methodsTwo PET scans, one of each with [(11)C]PIB and [(18)F]FACT, were performed sequentially on six normal control subjects, two mild cognitive impairment (MCI) patients, and six AD patients. The standardized uptake value ratio of brain regions to the cerebellum was calculated with partial volume correction using magnetic resonance (MR) images to remove the effects of white matter accumulation.

resultsNo significant differences in the cerebral cortical uptake were observed between normal control subjects and AD patients in [(18)F]FACT studies without partial volume correction, while significant differences were observed in [(11)C]PIB. After partial volume correction, the cerebral cortical uptake was significantly larger in AD patients than in normal control subjects for [(18)F]FACT studies as well as [(11)C]PIB. Relatively lower uptakes of [(11)C]PIB in distribution were observed in the medial side of the temporal cortex and in the occipital cortex as compared with [(18)F]FACT. Relatively higher uptake of [(11)C]PIB in distribution was observed in the frontal and parietal cortices.

conclusionSince [(18)F]FACT might bind more preferentially to dense-cored amyloid deposition, regional differences in cerebral cortical uptake between [(11)C]PIB and [(18)F]FACT might be due to differences in regional distribution between diffuse and dense-cored amyloid plaque shown in the autoradiographic and histochemical assays of postmortem AD brain sections.

Indexed as

BenzothiazolesPositron-Emission TomographyRadiopharmaceuticalsAgedAged, 80 and overAlzheimer DiseaseAniline CompoundsBenzoxazolesBrainCase-Control StudiesCognitive DysfunctionFemaleHumansMaleMiddle AgedPlaque, Amyloid2-((2-(2-(2-(dimethylamino)-1,3-thiazol-5-yl)vinyl)-1,3-benzoxazol-6-yl)oxy)-3-fluoropropan-1-ol2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazoleAniline CompoundsBenzothiazolesBenzoxazolesRadiopharmaceuticalsThiazoles

Identifiers

PMID24233004
OpenAlexW2003712011

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.